BIO Historical PE Ratio image   This BIO PE ratio history page last updated 5/23/2022
BIO Historical PE Ratio Chart
PeriodPriceAdj. EPSAnnualizedPE
Q1 2022
4/28/2022
513.114.9419.7626.0
Q4 2021
2/10/2022
625.173.2112.8448.7
Q3 2021
10/28/2021
788.823.7114.8453.2
Q2 2021
7/29/2021
707.133.5414.1649.9
Q1 2021
4/29/2021
640.735.2120.8430.7
Q4 2020
2/11/2021
643.814.0116.0440.1
Q3 2020
10/29/2020
568.033.0012.0047.3
Q2 2020
7/30/2020
535.601.616.4483.2
Q1 2020
5/6/2020
449.991.917.6458.9
Q4 2019
2/13/2020
379.342.329.2840.9
Q3 2019
10/31/2019
331.621.616.4451.5
Q2 2019
8/1/2019
310.371.576.2849.4
Q1 2019
5/8/2019
296.511.656.6044.9
Q4 2018
2/28/2019
270.902.138.5231.8
Q3 2018
11/1/2018
275.340.913.6475.6
Q2 2018
8/7/2018
308.971.646.5647.1
Q1 2018
5/8/2018
253.691.174.6854.2
Q4 2017
2/27/2018
254.001.506.0042.3
Q3 2017
11/2/2017
216.940.913.6459.6
Q2 2017
8/3/2017
242.280.170.68356.3
Q1 2017
5/4/2017
220.770.622.4889.0
Q4 2016
2/23/2017
192.000.783.1261.5
Q3 2016
11/1/2016
155.520.622.4862.7
Q2 2016
8/3/2016
145.771.024.0835.7
Q1 2016
5/5/2016
143.390.421.6885.4
Q4 2015
2/25/2016
132.051.686.7219.7
Q3 2015
11/3/2015
141.320.592.3659.9
Q2 2015
8/6/2015
144.711.124.4832.3
Q1 2015
5/5/2015
134.690.612.4455.2
Q4 2014
2/26/2015
119.001.345.3622.2
Q3 2014
11/4/2014
111.800.391.5671.7
Q2 2014
8/5/2014
116.181.094.3626.6
Q1 2014
5/6/2014
124.190.230.92135.0
Q4 2013
2/27/2014
130.971.044.1631.5
Q3 2013
11/7/2013
123.61-0.25-1.00NA
Q2 2013
8/6/2013
123.401.204.8025.7
Q1 2013
5/7/2013
111.660.682.7241.1
Q4 2012
2/26/2013
117.301.656.6017.8
Q3 2012
11/6/2012
103.251.485.9217.4
Q2 2012
8/7/2012
98.251.696.7614.5
Q1 2012
5/1/2012
108.151.094.3624.8
BIO PE History Chart
PeriodPriceAdj. EPSTTMPE
Q1 2022
4/28/2022
513.114.9415.4033.3
Q4 2021
2/10/2022
625.173.2115.6739.9
Q3 2021
10/28/2021
788.823.7116.4747.9
Q2 2021
7/29/2021
707.133.5415.7644.9
Q1 2021
4/29/2021
640.735.2113.8346.3
Q4 2020
2/11/2021
643.814.0110.5361.1
Q3 2020
10/29/2020
568.033.008.8464.3
Q2 2020
7/30/2020
535.601.617.4571.9
Q1 2020
5/6/2020
449.991.917.4160.7
Q4 2019
2/13/2020
379.342.327.1553.1
Q3 2019
10/31/2019
331.621.616.9647.6
Q2 2019
8/1/2019
310.371.576.2649.6
Q1 2019
5/8/2019
296.511.656.3346.8
Q4 2018
2/28/2019
270.902.135.8546.3
Q3 2018
11/1/2018
275.340.915.2252.7
Q2 2018
8/7/2018
308.971.645.2259.2
Q1 2018
5/8/2018
253.691.173.7567.7
Q4 2017
2/27/2018
254.001.503.2079.4
Q3 2017
11/2/2017
216.940.912.4887.5
Q2 2017
8/3/2017
242.280.172.19110.6
Q1 2017
5/4/2017
220.770.623.0472.6
Q4 2016
2/23/2017
192.000.782.8467.6
Q3 2016
11/1/2016
155.520.623.7441.6
Q2 2016
8/3/2016
145.771.023.7139.3
Q1 2016
5/5/2016
143.390.423.8137.6
Q4 2015
2/25/2016
132.051.684.0033.0
Q3 2015
11/3/2015
141.320.593.6638.6
Q2 2015
8/6/2015
144.711.123.4641.8
Q1 2015
5/5/2015
134.690.613.4339.3
Q4 2014
2/26/2015
119.001.343.0539.0
Q3 2014
11/4/2014
111.800.392.7540.7
Q2 2014
8/5/2014
116.181.092.1155.1
Q1 2014
5/6/2014
124.190.232.2255.9
Q4 2013
2/27/2014
130.971.042.6749.1
Q3 2013
11/7/2013
123.61-0.253.2837.7
Q2 2013
8/6/2013
123.401.205.0124.6
Q1 2013
5/7/2013
111.660.685.5020.3
Q4 2012
2/26/2013
117.301.655.9119.8
Q3 2012
11/6/2012
103.251.48NANA
Q2 2012
8/7/2012
98.251.69NANA
Q1 2012
5/1/2012
108.151.09NANA
Quotes delayed 20 minutes

Email EnvelopeFree BIO Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
Bio-Rad Laboratories (BIO) is categorized under the Healthcare sector; to help you further research PE history across stocks, below are some other companies in the same sector:

BIOC PE Ratio History
BIOL PE Ratio History
BIVI PE Ratio History
BKD PE Ratio History
BLCM PE Ratio History
BLFS PE Ratio History
BLI PE Ratio History
BLPH PE Ratio History
BLUE PE Ratio History
BMEA PE Ratio History
How should the BIO historical PE ratio be determined?
Realizing that PE stands for Price to Earnings ratio, we need two values to compute it: stock price and earnings per share. The stock price at any given date is a known historical value, but what about the earnings number to use?

✔️Accepted answer: There are a number of different approaches when it comes to calculating a historical PE ratio for a company like Bio-Rad Laboratories. We like to take our measurements on each of the past quarterly earnings reports. That only leaves the question of whether the earnings number at that quarterly report should be used on an annualized basis, or some other method. We approach this question using three different methods, on this BIO Historical PE Ratio page.

What is the average historical PE for BIO based on annualized quarterly earnings?
As we look back through earnings history, what is the resulting PE calculation if at each measurement period we use that quarter's earnings result annualized?

✔️Accepted answer: The BIO historical PE ratio using the annualized quarterly earnings method works out to 55.5.

What is the average historical PE for BIO based on trailing twelve month earnings?
As we look back through earnings history, what is the resulting PE calculation if at each measurement period we use the trailing twelve months combined earnings result in the calculation?

✔️Accepted answer: The BIO historical PE ratio using the TTM earnings method works out to 50.6.

What is the average historical PE for BIO based on median TTM earnings?
As we look back through earnings history, what is the resulting PE calculation if at each measurement period we use the median earnings over the trailing twelve months and annualize that median result in the calculation?

✔️Accepted answer: The BIO historical PE ratio using the annualized median TTM earnings method works out to 14.48.

On this page we presented the BIO Historical PE Ratio information for Bio-Rad Laboratories' stock. The average BIO historical PE based on using the annualized quarterly earnings result at each measurement period (for the "E" in the PE calculation; and the closing price on earnings date as the "P") is 55.5. Meanwhile, using the trailing twelve month (TTM) quarterly earnings result as our method of calculation the "E" value at each measurement period, the average BIO historical PE based on this TTM earnings result method is 50.6. Note: any PE calculations involving negative earnings were discarded as not meaningful.

Let's now compare this BIO historical PE result, against the recent PE: when this page was posted on 5/20/2022, the most recent closing price for BIO had been 522.20, and the most recent quarterly earnings result, annualized, was 19.76. Meanwhile, the most recent TTM earnings summed to 15.4. From these numbers, we calculate the recent BIO PE on 5/20/2022 based on annualized quarterly EPS was 26.4. Based on BIO's history, that recent PE is low relative to the historical average, with the recent PE 52.4% lower than the historical average PE across our data set for Bio-Rad Laboratories. Looking at the recent BIO PE on 5/20/2022 based on TTM EPS, we calculate the ratio at 33.9. Based on BIO's history, that recent PE is low relative to the historical average, with the recent PE 33.0% lower than the average PE across our Bio-Rad Laboratories data set with TTM EPS used in the calculation at each period.

Another interesting BIO historical PE Ratio calculation we look at is to take the median earnings per share of the last four quarters for BIO, and then annualize the resulting value... with that annualized number then being used in the PE calculation. To walk through this math for BIO, we start with the past four EPS numbers and we first sort them from lowest to highest: 3.21, 3.54, 3.71, and 4.94. We then toss out the highest and lowest result, and then take the average of those two middle numbers — 3.54 and 3.71 — which gives us the median of 3.62. Basically the way to think about this 3.62 number is this: for the trailing four earnings reports, 3.62 marks the "middle ground" number where BIO has reported a value higher than 3.62 half the time, and has reported a value lower than 3.62 half the time. Annualizing that median value then gets us to 14.48/share, which we use as the denominator in our next PE calculation. With 522.20 as the numerator (as of 5/20/2022), the calculation is then 522.20 / 14.48 = 36.1 as the BIO PE ratio as of 5/20/2022, based on that annualized median value we calculated.

For self directed investors doing their due diligence on BIO or any other given stock, valuation analysis for BIO can greatly benefit from studying the past earnings and resulting PE calculations. This exercise can help inform an analysis as to whether the past earnings trajectory and current versus historical PE ratios justify the current stock value.

That's why we bring you HistoricalPERatio.com to make it easy for investors to investigate Bio-Rad Laboratories PE history or the past PE information for any stock in our coverage universe. And in your continued research we hope you will be sure to check out the further links included for earnings surprises history (beat/miss data) as well as next earnings dates for BIO. Thanks for visiting, and the next time you need to research BIO Historical PE Ratio or the ratio for another stock, we hope you'll think of our site, as your go-to historical PE ratio research resource of choice.

Recommended: Top Ten Hedge Funds Holding KLR, Institutional Holders of PLRG, Institutional Holders of IPK.

 

BIO Historical PE Ratio | www.HistoricalPERatio.com | Copyright © 2020 - 2022, All Rights Reserved

Nothing in HistoricalPERatio.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.